arrow
T

Takashi Sasaki

department of hepato-biliary-pancreatic medicine
H指数:42
被引数:5,569

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of subcutaneous adiposity with survival outcomes in advanced biliary tract cancer treated with gemcitabine, cisplatin, and immune checkpoint inhibitor

皮下脂肪量与接受吉西他滨、顺铂和免疫检查点抑制剂治疗的晚期胆道癌患者生存结局的关联

2026-08-140
PRE
Changing treatment outcomes in metastatic and recurrent pancreatic cancer: a real-world comparison before and after the availability of nanoliposomal irinotecan

改变转移性和复发性胰腺癌的治疗结局:纳米脂质体伊立替康可用性前后的真实世界比较

2025-12-010
PRE
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab

不可切除的肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后的三年总生存率

2025-08-280
PRE
Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases

胰腺癌肝转移消失的临床意义: 结直肠癌肝转移的经验教训

EJSO
IF2.9
2025-05-010
PRE
Efficacy and safety of a novel multihole fully covered self-expandable metallic stent for malignant distal biliary obstruction: Multicenter retrospective study
2025-03-010
OA
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
2024-11-251
OA
Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC
2024-09-042
PRE